ArticleFrontiers in immunology2023

Editorial: Immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy.

Er-Lei ZhangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.